Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon
Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Raynaud's phenomenon (RP) is a disorder of the digital blood vessels resulting in episodic
impairment of blood flow. During an attack of RP which commonly affects the hands and feet
these arteries contract briefly which limits the blood flow (this is called a vasospasm) and
deprived of blood the skin turns white then blue. The aim of this study is to prove the
concept that ORM-12741 can prevent these blood vessel spasms.